- Home
- JUNS vs EIC Comparison
JUNS vs EIC Comparison
Compare JUNS & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JUNS
- EIC
- Stock Information
- Founded
- JUNS 2015
- EIC N/A
- Country
- JUNS United States
- EIC United States
- Employees
- JUNS N/A
- EIC N/A
- Industry
- JUNS
- EIC Finance/Investors Services
- Sector
- JUNS
- EIC Finance
- Exchange
- JUNS NYSE
- EIC Nasdaq
- Market Cap
- JUNS 17.6M
- EIC 355.7M
- IPO Year
- JUNS 2024
- EIC 2019
- Fundamental
- Price
- JUNS $0.62
- EIC $14.36
- Analyst Decision
- JUNS
- EIC Strong Buy
- Analyst Count
- JUNS 0
- EIC 1
- Target Price
- JUNS N/A
- EIC $17.50
- AVG Volume (30 Days)
- JUNS 103.2K
- EIC 186.3K
- Earning Date
- JUNS 05-20-2025
- EIC 05-20-2025
- Dividend Yield
- JUNS N/A
- EIC 16.67%
- EPS Growth
- JUNS N/A
- EIC N/A
- EPS
- JUNS N/A
- EIC 1.97
- Revenue
- JUNS N/A
- EIC $46,223,036.00
- Revenue This Year
- JUNS N/A
- EIC $39.61
- Revenue Next Year
- JUNS N/A
- EIC $27.28
- P/E Ratio
- JUNS N/A
- EIC $7.33
- Revenue Growth
- JUNS N/A
- EIC 72.79
- 52 Week Low
- JUNS $0.51
- EIC $12.73
- 52 Week High
- JUNS $19.51
- EIC $16.71
- Technical
- Relative Strength Index (RSI)
- JUNS N/A
- EIC 50.89
- Support Level
- JUNS N/A
- EIC $13.82
- Resistance Level
- JUNS N/A
- EIC $14.67
- Average True Range (ATR)
- JUNS 0.00
- EIC 0.22
- MACD
- JUNS 0.00
- EIC 0.11
- Stochastic Oscillator
- JUNS 0.00
- EIC 72.07
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
About EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.